DKC1 and prostate carcinoma: Unfortunately, we could not perform a systematic analysis in paraffin-embedded benign or cancerous prostate cancer tissues from archival samples, as the commercial polyclonal antibody successfully used in western blotting with nuclear extracts (Figures 3 and 4) detected nucleolar dyskerin expression in a subset of normal uterine cervical cells, but only in very few prostate cancer cells, and the polyclonal antibody used on breast cancers (Montanaro et al, 2006) is depleted.